Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
11.42
+1.70 (17.49%)
At close: Jul 16, 2025, 4:00 PM
11.46
+0.04 (0.35%)
After-hours: Jul 16, 2025, 7:57 PM EDT
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Vicarious Surgical stock have a consensus rating of "Hold" and an average price target of $9.25, which forecasts a -19% decrease in the stock price over the next year. The lowest target is $8.5 and the highest is $10.
Price Target: $9.25 (-19%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
The average analyst rating for Vicarious Surgical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $11 → $8.5 | Hold | Maintains | $11 → $8.5 | -25.57% | Mar 18, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | -8.06% | Nov 13, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $12 | Hold | Maintains | $30 → $12 | +5.08% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | -12.43% | Jul 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $45 → $30 | Hold | Maintains | $45 → $30 | +162.70% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
n/a
from 68.24M
Revenue Next Year
n/a
EPS This Year
-9.63
from -10.74
EPS Next Year
-7.14
from -9.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | 37.8M | ||
| Avg | n/a | n/a | 22.4M | ||
| Low | n/a | n/a | 8.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -9.09 | -3.92 | -2.96 |
| Avg | -9.63 | -7.14 | -5.63 |
| Low | -10.18 | -9.99 | -9.22 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.